Younguk Kim

Dr. Younguk Kim

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in Sensors
Verified
Journal Article
Open access
PDF file
YKYounguk Kim
Younguk Kim
BSBrittany Smith
Brittany Smith
LSLara Shigo
Lara Shigo
ASAasef Shaikh
Aasef Shaikh
KLKenneth A. Loparo
Kenneth A. Loparo
ARAngela L. Ridgel
Angela L. Ridgel
Background and Purpose: This pilot randomized controlled trial evaluated the effects of 12 sessions of patient-specific adaptive dynamic cycling (PSADC) versus non-adaptive cycling (NA) on motor function and mobility in individuals with Parkinson’s disease (PD), using inertial measurement unit (IMU) sensors for objective assessment. Methods: Twenty-three participants with PD (13 in the PSADC group and 10 in the NA group) completed the study over a 4-week period. Motor function was measured using the Kinesia™ sensors and the MDS-UPDRS Motor III, while mobility was assessed with the TUG test using OPAL IMU sensors. Results: The PSADC group showed significant improvements in MDS-UPDRS Motor III scores (t = 5.165, p < 0.001) and dopamine-sensitive symptoms (t = 4.629, p = 0.001), whereas the NA group did not improve. Both groups showed non-significant improvements in TUG time. IMU sensors provided continuous, quantitative, and unbiased measurements of motor function and mobility, offering a more precise and objective tracking of improvements over time. Conclusions: PSADC demonstrated enhanced treatment effects on PD motor function compared to NA while also reducing variability in individual responses. The integration of IMU sensors was essential for precise monitoring, supporting the potential of a data-driven, individualized exercise approach to optimize treatment outcomes for individuals with PD.

1 December 2025 in Journal of Aging and Physical Activity
Verified
Journal Article
Closed access
PDF file
YKYounguk Kim
Younguk Kim
JKJin Hyun Kim
Jin Hyun Kim
ARAngela L. Ridgel
Angela L. Ridgel
Background : Parkinson’s disease (PD) affects motor and nonmotor functions, impacting PD-related quality of life. The role of physical activity (PA) in the management of PD symptoms is increasingly recognized. Purpose : To examine the effects of PA levels on PD motor and nonmotor symptoms, and health-related quality of life, using the Fox Insight study’s data set. It also examines PA’s moderating effects on the age–PD motor function relationship. Methods : In this cross-sectional observational study, 1,288 participants with PD (55.8% men, age: 64.54 ± 9.99) from the Fox Insight study were divided into four groups ( N = 322 each) based on their PA level as measured by the Physical Activity Scale for the Elderly (PASE). PD motor and nonmotor symptoms were assessed using the Unified Parkinson’s Disease Rating Scale-2 (UPDRS-2), Parkinson’s Disease Questionnaire-8 (PDQ-8), Geriatric Depression Scale–Short Form, Penn Parkinson’s Daily Activities Questionnaire-15, and EuroQol-Visual Analog Scale. Statistical analyses included Kruskal–Wallis, Pearson’s correlation, and multiple linear regression, with alpha set at .05. Results : Higher PASE correlated with better UPDRS-2, Parkinson’s Disease Questionnaire-8, Geriatric Depression Scale–Short Form, Penn Parkinson’s Daily Activities Questionnaire-15, and EuroQol-Visual Analog Scale. The study found significant influences of PASE on UPDRS-2, age, Geriatric Depression Scale–Short Form, body mass index, and EQ-VAS ( R 2 adj = .174, F = 53.998, p < .001). Notably, PASE moderated the relationship between age and UPDRS-2, suggesting a pivoting role in slowing PD-related symptom progression with age ( R 2 adj = .145, F = 73.47, p < .001). Conclusion : Increased PA levels are associated with better outcomes in PD motor and nonmotor symptoms, improved PD-related quality of life, and a slowed progression of PD symptoms. Implications : Promoting higher levels of PA in older adults with PD effectively manages motor and nonmotor symptoms of PD. In addition, early and consistent PA is the key to moderating the progression of PD symptoms.

5 August 2024 in Neurorehabilitation and Neural Repair
Verified
Journal Article
Closed access
YKYounguk Kim
Younguk Kim
BSBrittany E. Smith
Brittany E. Smith
LSLara Shigo
Lara Shigo
ASAasef G. Shaikh
Aasef G. Shaikh
KLKenneth A. Loparo
Kenneth A. Loparo
ARAngela L. Ridgel
Angela L. Ridgel
Background: Previous studies have established that increased Sample Entropy (SampEn) of cadence, a measure of non-linear variability, during dynamic cycling leads to greater improvements in motor function for individuals with Parkinson’s disease (PD). However, there is significant variability in responses among individuals with PD due to symptoms and disease progression. Objectives: The aim of this study was to develop and test a paradigm for adapting a cycling exercise intervention using SampEn of cadence and rider effort to improve motor function. Methods: Twenty-two participants were randomized into either patient-specific adaptive dynamic cycling (PSADC) or non-adaptive (NA) group. SampEn of cadence was calculated after each of the 12 sessions, and motor function was evaluated using the Kinesia test. Pearson’s correlation coefficient was used to analyze the relationship between SampEn of cadence and motor function improvement. Multiple linear regression (MLR) was used to identify the strongest predictors of motor function improvement. Results: Pearson’s correlation coefficient revealed a significant correlation between SampEn of cadence and motor function improvements ( R2 = −.545, P = .009), suggesting that higher SampEn of cadence led to greater motor function improvement. MLR demonstrated that SampEn of cadence was the strongest predictor of motor function improvement (β = −8.923, t = −2.632, P = .018) over the BMI, Levodopa equivalent daily dose, and effort. Conclusions: The findings show that PSADC paradigm promoted a greater improvement in motor function than NA dynamic cycling. These data will be used to develop a predictive model to optimize motor function improvement after cycling in individuals with PD.

18 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
YKYounguk Kim
Younguk Kim
BSBrittany Smith
Brittany Smith
LSLara Shigo
Lara Shigo
ASAasef Shaikh
Aasef Shaikh
KLKenneth A. Loparo
Kenneth A. Loparo
ARAngela L. Ridgel
Angela L. Ridgel
Background and Purpose: This pilot randomized controlled trial evaluated the effects of 12 sessions of patient-specific adaptive dynamic cycling (PSADC) versus non-adaptive cycling (NA) on motor function and mobility in individuals with Parkinson’s disease (PD), using IMU sensors for objective assessment. Methods: Twenty-three participants with PD (13 in the PSADC group and 10 in the NA group) completed the study over a 4-week period. Motor function was measured using the Kinesia™ sensors and the MDS-UPDRS Motor III, while mobility was assessed with the TUG test using OPAL IMU sensors. Results: The PSADC group showed significant improvements in MDS-UPDRS Motor III scores (t = 5.165, p < 0.001) and dopamine-sensitive symptoms (t = 4.629, p = 0.001), whereas the NA group did not improve. Both groups showed non-significant improvements in TUG time. IMU sensors provided continuous, quantitative, and unbiased measurements of motor function and mobility, offering a more accurate tracking of improvements over time. Conclusion: PSADC demonstrated enhanced treatment effects on PD motor function compared to NA, while also reducing variability in individual responses. The integration of IMU sensors was essential for precise monitoring, supporting the feasibility of a data-driven, individualized exercise approach to optimize treatment outcomes for individuals with PD.

15 January 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
YKYumi Kim
Yumi Kim
JRJIM H RIMMER
JIM H RIMMER
BLByron Lai
Byron Lai
RORobert Alan Oster
Robert Alan Oster
RCRachel Cowan
Rachel Cowan
Jereme WilroyJereme Wilroy
Jereme Wilroy
Background: Wheelchair users live predominantly sedentary lifestyles and have a substantially higher risk for cardiometabolic disease and mortality compared to people without disabilities. Exercise training has been found to be effective in improving cardiometabolic health (CMH) outcomes among people without disabilities, but research on wheelchair users is limited and of poor quality. Objective: The primary aim of this study is to examine the immediate and sustained effects of a 24-week, telehealth, movement-to-music cardiovascular (M2M-C) exercise program on core indicators of CMH among adult wheelchair users compared to an active control group. The secondary aim is to explore the beneficial effects of M2M-C exercises on cardiovascular capacity, physical activity, and quality of life. Intervention components include tailored exercises and remote performance monitoring, delivered via live videoconference training by a telecoach and asynchronous videos. Methods: This study’s design is a parallel-arm randomized controlled trial enrolling 132 physically inactive adult wheelchair users with poor cardiometabolic profiles. The M2M-C intervention group involves 24 weeks of virtual live and monitored home exercise training (3×/wk, 15-40 min/session), followed by a 12-week maintenance period where participants have access to an online media library of exercise videos. The control group involves 36 weeks of self-guided exercise through access to a media library of exercise videos, including videos for range of motion, muscle strength, and balance. The primary outcomes are cardiometabolic indicators of health, and assessors are blinded. Results: Recruitment procedures started in January 2024 with the first participant enrolled on March 18, 2024. All data are anticipated to be collected by November 2027, and the main results of the trial are anticipated to be published by February 2028. Secondary analyses of data will be subsequently published. A total of 16 participants have been recruited as of paper submission. Conclusions: The knowledge obtained from this trial will provide evidence to inform exercise prescriptions aimed at improving CMH among adult wheelchair users. Trial Registration: ClinicalTrials.gov NCT05606432; https://clinicaltrials.gov/study/NCT05606432 International Registered Report Identifier (IRRID): DERR1-10.2196/57423

1 July 2020 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
YKYounguk Kim
Younguk Kim
JKJin Hyun Kim
Jin Hyun Kim
ZLZachary Lemke
Zachary Lemke
ARAngela L. Ridgel
Angela L. Ridgel